Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy 23andMe Holding stock
Learn how to easily invest in 23andMe Holding stock.
Genetic testing company 23andMe is going public via a special purpose acquisition company (SPAC). We'll update this page as new information becomes available.
How to buy shares in 23andMe Holding
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ME – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
23andMe Holding stock price (NASDAQ: ME)Use our graph to track the performance of ME stocks over time.
23andMe Holding shares at a glance
|Latest market close||$3.24|
|52-week range||$2.12 - $13.68|
|50-day moving average||$3.39|
|200-day moving average||$3.80|
|Wall St. target price||$5.58|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.60|
Buy 23andMe Holding shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy 23andMe Holding stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
23andMe Holding price performance over time
|1 week (2022-09-29)||8.36%|
|1 month (2022-09-06)||0.62%|
|3 months (2022-07-06)||12.89%|
|6 months (2022-04-06)||-9.50%|
|1 year (2021-10-06)||-59.50%|
|2 years (2020-10-02)||N/A|
|3 years (2019-10-02)||N/A|
|5 years (2017-10-02)||N/A|
23andMe Holding financials
|Revenue TTM||$277.2 million|
|Gross profit TTM||$132.9 million|
|Return on assets TTM||-17.6%|
|Return on equity TTM||-34.94%|
|Market capitalisation||$1.4 billion|
TTM: trailing 12 months
23andMe Holding share dividends
We're not expecting 23andMe Holding to pay a dividend over the next 12 months.
23andMe Holding overview
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications based on genetic testing of a saliva sample through its spit kit. The Therapeutics segment focuses on the drug development; and discovery and development of novel therapies to improve patient lives across various therapeutic areas, including oncology, respiratory, and cardiovascular diseases, as well as offers out-licensing of intellectual property associated with identified drug targets related to drug candidates under clinical development. It has a collaboration agreement with GlaxoSmithKline Intellectual Property (No. 3) Limited to leverage genetic insights to validate, develop, and commercialize drugs.
23andMe Holding in the news
23andMe Announces Trials-in-Progress Poster Presentation on 23ME-00610, An Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancer’s (SITC) 2022 Annual Meeting
7 Undervalued Reddit Stocks to Buy Before Wall Street Catches On
Daniel Chu Joins 23andMe as Chief Product Officer
Frequently asked questionsWhat percentage of 23andMe Holding is owned by insiders or institutions?
Currently 5.087% of 23andMe Holding shares are held by insiders and 38.348% by institutions. When does the fiscal year end for 23andMe Holding?
23andMe Holding's fiscal year ends in March. Where is 23andMe Holding based?
23andMe Holding's address is: 349 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 What is 23andMe Holding's ISIN number?
23andMe Holding's international securities identification number is: US90138Q1085
More guides on Finder
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
Invest in FAANG stocks
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert